"Das Klinikum Bremerhaven-Reinkenheide ist das städtische Krankenhaus für Bremerhaven und die Region. Als Klinikum der Maximalversorgung sichern wir die Gesundheitsversorgung für Stadt und Land – rund um die Uhr und Tag für Tag. Unseren Patientinnen und Patienten bieten wir bestmögliche Versorgung mit 813 Betten, 14 Kliniken, 2 Instituten, einem medizinischen Versorgungszentrum und einem mit externen Kardiologen betriebenen Herzkatheterlabor. Mit rund 2.000 Beschäftigten und 813 Betten sind wir das größte Krankenhaus in der Unterweserregion und einer der größten Ausbildungsbetriebe in Bremerhaven."

During the past decade, Klinikum Bremerhaven-Reinkenheide gGmbH conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Bremerhaven-Reinkenheide gGmbH" #1 sponsor was "Boehringer Ingelheim" with 1 trials, followed by "Drägerwerk AG & Co. KGaA" with 1 trials sponsored, "EuMelaReg gGmbH" with 1 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials sponsored and "III. Medizinische Klinik Mannheim" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Bremerhaven-Reinkenheide gGmbH" #1 collaborator was "Center for Clinical Trials Philipps University Marburg" with 1 trials as a collaborator, "Deutsche Krebshilfe e.V., Bonn (Germany)" with 1 trials as a collaborator, "Dietmar Hopp Stiftung GmbH" with 1 trials as a collaborator, "European Union" with 1 trials as a collaborator and "Fraunhofer Institute for Interfacial Engineering and Biotechnology" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Bremerhaven-Reinkenheide gGmbH" are "Parkinson's Disease" (4 trials), "ALI - Acute Lung Injury" (1 trials), "ARDS" (1 trials), "Atrial Fibrillation" (1 trials) and "Brain Ischemia With Non-valvular Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Klinikum Bremerhaven-Reinkenheide gGmbH" in a lesser frequency.

Most popular intervention types in "Klinikum Bremerhaven-Reinkenheide gGmbH" are "Drug" (7 trials), "Other" (3 trials), "Radiation" (3 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (2 trials), "radiation therapy" (2 trials), "Dabrafenib and Trametinib" (1 trials), "Lung Monitoring with EIT device (PulmoVista 500)" (1 trials) and "ND0612" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Bremerhaven-Reinkenheide gGmbH" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Bremerhaven-Reinkenheide gGmbH". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Klinikum Bremerhaven-Reinkenheide gGmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Bremerhaven-Reinkenheide gGmbH, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Klinikum Bremerhaven-Reinkenheide gGmbH has several departments that took part in Clinical trials: "Klinikum Bremerhaven-Reinkenheide gGmbH, Neurologische Klinik" - 2 trials